These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16336933)

  • 1. Collaborative study to establish a new biological reference preparation for prekallikrein activator.
    Longstaff C; Behr-Gross ME; Daas A; Lackner F
    Pharmeuropa Bio; 2005 Sep; 2005(1):1-12. PubMed ID: 16336933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An international collaborative study to replace the 1st international standard for prekallikrein activator.
    Longstaff C; Behr-Gross ME; Daas A; Lackner F
    Vox Sang; 2005 Feb; 88(2):143-51. PubMed ID: 15720613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborative study for the calibration of the Ph. Eur. prekallikrein activator in albumin BRP batches 4, 5 and 6.
    Lackner F; Daas A; Terao E
    Pharmeur Bio Sci Notes; 2015; 2015():1-10. PubMed ID: 26830155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of replacement batches for prekallikrein activator in albumin biological reference preparation.
    Lackner F; Daas A; Terao E; Behr-Gross ME
    Pharmeuropa Bio; 2008 Dec; 2008(1):1-6. PubMed ID: 19220976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint WHO/EDQM Collaborative study for the establishment of WHO 3
    Fox B; Regourd E; Rigsby P; Longstaff C; Terao E
    Pharmeur Bio Sci Notes; 2024; 2024():106-126. PubMed ID: 39010792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calibration of human coagulation factor VIII concentrate Ph. Eur. BRP Batch 4 for use in potency assays.
    Raut S; Costanzo A; Daniels S; Heath A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):1-29. PubMed ID: 21144486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calibration of European pharmacopoeia biological reference preparation for diphtheria vaccine (adsorbed) batch 4.
    Stickings P; Rigsby P; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):1-9. PubMed ID: 20144448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of European Pharmacopoeia BRP batch 2 for inactivated poliomyelitis vaccine for in vitro D antigen assay.
    Fuchs F; Minor P; Daas A; Milne C
    Pharmeuropa Bio; 2003 Jul; 2003(1):23-50. PubMed ID: 14563307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
    Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
    Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A collaborative study to establish the 1st national standard of prekallikrein activator in Korea.
    Shin IS; Hong CM; Ban SJ; Hong SH
    Biologicals; 2012 Jan; 40(1):79-83. PubMed ID: 22122985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative study for the establishment of the Ph. Eur. BRP batch 1 for anti-vaccinia immunoglobulin.
    Fuchs F; Poirier B; Leparc-Goffart I; Buchheit KH
    Pharmeuropa Bio; 2005 Sep; 2005(1):13-8. PubMed ID: 16336934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a biological reference preparation for hepatitis A vaccine (inactivated, non-adsorbed).
    Stalder J; Costanzo A; Daas A; Rautmann G; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):15-29. PubMed ID: 20223187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calibration of human coagulation factor VII concentrate Ph. Eur. BRP batch 2.
    Dodt J; Costanzo A; Daas A; Hunfeld A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):31-8. PubMed ID: 20223188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaborative study for establishment of a European Pharmacopoeia Biological Reference Preparation (BRP) for B19 virus DNA testing of plasma pools by nucleic acid amplification technique.
    Nübling CM; Daas A; Buchheit KH
    Pharmeuropa Bio; 2004 Jan; 2003(2):27-34. PubMed ID: 14960261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calibration of the Ph. Eur. human coagulation Factor VIII Concentrate BRP batch 6.
    Raut S; Le Tallec D; Costanzo A
    Pharmeur Bio Sci Notes; 2021; 2021():88-100. PubMed ID: 33973517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collaborative study for the establishment of erythropoietin BRP batch 3.
    Behr-Gross ME; Daas A; Burns C; Bristow AF
    Pharmeuropa Bio; 2007 Dec; 2007(1):49-66. PubMed ID: 18413137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative study for the establishment of tetanus vaccine (adsorbed) Third International Standard and European Pharmacopoeia Biological Reference Preparation batch no. 2.
    Sesardic D; Winsnes R; Rigsby P; Gaines-Das R
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):45-72. PubMed ID: 11705100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European Pharmacopoeia biological reference preparation for poliomyelitis vaccine (inactivated): collaborative study for the establishment of batch No. 3.
    Martin J; Daas A; Milne C
    Pharmeur Bio Sci Notes; 2016; 2016():135-150. PubMed ID: 28279255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative study for the establishment of Infliximab Biological Reference Preparation Batch 1.
    Wadhwa M; Rigsby P; Behr-Gross ME
    Pharmeur Bio Sci Notes; 2020; 2020():49-52. PubMed ID: 32459170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.